Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting (Tables)

v3.19.3.a.u2
Segment Reporting (Tables)
9 Months Ended
Sep. 30, 2019
Segment Reporting [Abstract]  
Schedule of Segment Information

Selected financial information for the Company’s operating segments is as follows:

 

   

Three Months Ended

September 30,

   

Nine Months Ended

September 30,

 
    2019     2018     2019     2018  
Net revenues - External                                
Hospital Operations   $ 3,920,608     $ 5,021,543     $ 13,081,647     $ 9,755,099  
Clinical Laboratory Operations     (34,631 )     17,569       56,169       177,890  
    $ 3,885,977     $ 5,039,112     $ 13,137,816     $ 9,932,989  
(Loss) income from continuing operations before income taxes:                                
Hospital Operations   $ (1,769,400 )   $ (1,294,581 )   $ (8,946,720 )     (3,998,943 )
Clinical Laboratory Operations     (295,908 )     (547,041 )     (701,466 )     (1,765,395 )
Corporate     (640,044 )     (973,953 )     (2,626,953 )     (3,156,646 )
Other income (expense), net     (9,422,340 )     100,171,656       (26,064,924 )     4,955,262  
    $ (12,127,692 )   $ 97,356,081     $ (38,340,063 )   $ (3,965,722 )
Depreciation and amortization                                
Hospital Operations     182,832     $ 39,669     $ 532,979     $ 177,386  
Clinical Laboratory Operations     10,036       112,908       69,381       625,877  
Corporate     7,128       248       7,458       811  
    $ 199,996     $ 152,825     $ 609,818     $ 804,074  
Capital expenditures                                
Hospital Operations   $ 7,086     $ 103,387     $ 50,801     $ 103,387  
Clinical Laboratory Operations     -       -       -       -  
    $ 7,086     $ 103,387     $ 50,801     $ 103,387  

 

    As of  
    September 30, 2019     December 31, 2018  
Total assets                
Hospital Operations   $ 16,831,443     $ 13,568,933  
Clinical Laboratory Operations     356,854       271,426  
Corporate     1,821,952       2,707,416  
Assets of AMSG and HTS classified as held for sale     373,121       152,171  
Eliminations     (2,809,305 )     (2,500,646 )
    $ 16,574,065     $ 14,199,300